1. Home
  2. GNSS vs GNTA Comparison

GNSS vs GNTA Comparison

Compare GNSS & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genasys Inc.

GNSS

Genasys Inc.

HOLD

Current Price

$2.21

Market Cap

98.4M

ML Signal

HOLD

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.44

Market Cap

34.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNSS
GNTA
Founded
1992
2014
Country
United States
Italy
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.4M
34.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GNSS
GNTA
Price
$2.21
$1.44
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.25
N/A
AVG Volume (30 Days)
154.4K
92.8K
Earning Date
02-10-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,757,000.00
N/A
Revenue This Year
$83.82
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
69.76
N/A
52 Week Low
$1.46
$1.28
52 Week High
$3.73
$10.00

Technical Indicators

Market Signals
Indicator
GNSS
GNTA
Relative Strength Index (RSI) 49.56 36.07
Support Level $2.15 $1.28
Resistance Level $2.30 $1.68
Average True Range (ATR) 0.12 0.17
MACD 0.00 0.02
Stochastic Oscillator 59.62 27.42

Price Performance

Historical Comparison
GNSS
GNTA

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: